Industry stakeholders are invested in personalized medicine, but the move toward a new era has been fraught with challenges. During the Summit’s welcome and introduction, the Personalized Medicine Coalition will set the tone for the day by presenting quantitative data on the status of industry’s efforts in personalized medicine and an analysis of the challenges to continued progress. PMC’s talk will illustrate, among other trends, the impressive pace at which new personalized medicines are reaching the marketplace.
Christopher J. Wells, MPA, Director, Communications, Personalized Medicine Coalition